Poster Presentation Instruction

All Posters will appear on poster board in the Main Hall and are available for viewing for participants at all times during the conference.

Below please find poster presentation guidelines:

  • Posters should be prepared in PORTRAIT format of dimensions NO MORE than 70 cm (width) x 90 cm (height). 
  • All the material necessary for attaching the poster to the poster board is available at the posters’ help desk in the respective poster area. 
  • Authors are responsible for setting up and removing their posters. 
  • Abstract title, author(s) and affiliation(s) should appear on top of the poster. 
  • Please make sure that your poster can be read easily from a distance of 2 meters. 
  • All posters must be prepared in English. 
  • Your poster should be hung on the board that has your presentation number indicated above.
  • It is recommended to allocate the top part of the poster for the title, authors' names and institutions, as they appear in the abstract.



Set-Up, Presentation and Dismantle Schedule: Posters have been assigned to one of the below poster sessions.

POSTER SESSION 1 l Thursday, 14 November


​07:30 – 08:00

Poster Viewing:

10:00 – 10:30 l 13:00 – 14:00 l 15:30 – 16:00

​Poster Session Hour:

17:45 - 18:45


19:45 – 20:45

 POSTER SESSION 2 l Friday, 15 November


​08:00 – 08:30

Poster Viewing:

10:00 – 10:30 l 12:00 – 13:0015:00 – 15:30

​Poster Session Hour:

17:00 - 18:00


18:00 – 18:30

Poster session will be held to allow participants to view research findings and interact with authors at the respective poster area. Please be present near your poster for possible questions from participants and session moderators.

Further any question or information, please do not hesitate to contact us.

Looking forward to welcome you at 10th Conference of the International Society for Affective Disorders (ISAD) in London.

Poster Presentation List:

Abstract Number Title Presenter Country
P-003 Heart rate variability associated with suicidality in depressed patients Andreas Menke Germany
P-004 Depression, anxiety, and somatic symptoms in older age: associations with cognition Anton Heretik Slovakia
P-005 Towards a new CNS biology based in the unsuspected bioenergetic role of Neuromelanin. Arturo Solis Herrera Mexico
P-006 Genetic Studies in Mood Disorders and Psychosis in a Genetic Isolate Carlos López Jaramillo Colombia
P-007 rTMS in Major Depressive Disorder: treatment duration is a key element in treatment succes Choi Deblieck Belgium
P-008 The risk of incident dementia according to the categorization of depression: preliminary findings from the prospective cohort study Dae Jong Oh South Korea
P-009 Sleep-wake rhythm in bipolar disorder measured by a smartphone app Frederike T. Fellendorf Austria
P-010 Emotional support and white matter hyperintensities in depressed older adults Grace Eun Kim South Korea
P-011 Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine Jad Kesserwani United Kingdom
P-012 The influences of white matter hyperintensities volume on depression, gait and quality of life patients with Alzheimer`s disease Joon Hyuk Park South Korea
P-013 Semantic Measures Based on Open-ended Word Responses analyzed with Artificial Intelligence Predict Individual Rating Scale Items for Depression, Anxiety and Worry Well Katarina Kjell Sweden
P-015 Association between erythrocyte indices and depressive symptoms in the community-dwelling elderly Ki Woong Kim South Korea
P-016 Vitamin D and affective disorders: A systematic review Krzysztof Maria Wilczyński Poland
P-017 A study combining whole-exome sequencing and structural neuroimaging analysis for major depressive disorder Kyu-Man Han South Korea
P-018 Drug use/resistant pathology in adolescence as a risk mark for affective disorders Laura Carpio García Spain
P-019 Biological Condition for Anorexia of Female Adolescents: Different Blood Types Mother/Daughter with Traumatic Contact Between Mother/Daughter Blood During Pregnancy and/or Birth Lorenzo Bracco Italy
P-020 Personalised goal attainment after a switch to vortioxetine in adults with major depressive disorder: results of a phase 4 open-label clinical trial Maggie Mccue United States
P-021 Altered emotional neural processing in major depressive disorder; a Magnetoencephalography (MEG) study in Saudi Arabia Maha Alqahtany Saudi Arabia
P-022 Between network analyses in Bipolar Disorder revealed increased resting state network activity: First evidence from the Mandrake Study Marcella Bellani Italy
P-023 Low Dose Ketamine Infusions for Suicide Ideation among Patients with Bipolar and Unipolar Treatment Refractory Depression. An Open Label Clinical Study Maria Eugenia Kulcar Argentina
P-026 Cognitive impairment in bipolar disorder or dementia: in the case of a clinical case in the elderly María Suárez Gómez Spain
P-027 The ENLIGHTEN-Early Study: Current Baseline Demographics of Adults With Recent-Onset Schizophrenia, Schizophreniform, or Bipolar I Disorder Mark Berry United States
P-028 Improvements in workplace productivity in working patients with major depressive disorder: results from the AtWoRC study Mayura Deshpande United Kingdom
P-029 A functional magnetic resonance imaging study of manic patients versus healthy controls using the CMET task Merce Madre Spain
P-030 An update on adjunctive agents for unipolar treatment resistant depression: A network meta-analysis Nicolas Nunez  
P-031 First manic episode after corticosteroid treatment of an olanzapine-induced DRESS syndrome Pedro Oliveira Portugal
P-032 Differential Therapeutic Effects Of Add-on Group V/S Individual Yoga Therapy In Unipolar Depression: A Single Blinded Randomized Controlled Study Pratham Dua India
P-033 Efficacy of transcranial direct current stimulation treatment in old age depression: A meta-analysis of individual level data (IPD) Rachael M. Rimmer United Kingdom
P-034 Prediction of outcome in patients with treatment resistant depression receiving multimodal inpatient treatment Rachael Taylor United Kingdom
P-035 Using IV Ketamine More Effectively: Safety and Efficacy of 100-minute versus 40-minute infusions for Refractory Depression Sagar Parikh United States
P-036 Early administration of aripiprazole long-acting injectable in acute psychotic inpatients reduce hospitalization stay Santiago Ovejero Spain
P-037 Do We Always Choose What Is Right for Us? Individuals Differ in the Ability to Employ and Benefit From Different Emotion Regulation Strategies Shilat Haim Nachum Israel
P-038 White matter hyperintensity shape and depressive symptoms in Alzheimer’s disease patients Subin Lee South Korea
P-039 Association between Protein Intake and Depression in the United States and South Korea: Analysis of the National Health and Nutrition Examination Survey Tae Suk Kim South Korea
P-042 A study of the quality of life and personality traits of NEO five factors concerning bipolar patients in remission, most recent episode mania Iulia Virtosu Romania
P-043 The severity of depressive symptoms in PTSD patients related to increased ACTH levels Ana Teresa D. Delia Brazil
P-044 Serotonin transporter availability in patients with anxious and non-anxious depression: a study design Andreas Menke Germany
P-045 Illness insight and medication adherence among psycho-educated bipolar disorder patients Carmen Maura Carrillo De Albornoz Calahorro Spain
P-046 Caffeine consumption among Bipolar Disorder Carmen Maura Carrillo De Albornoz Calahorro Spain
P-047 Affective disorder following psychosis: a diverse nosological entity? Carmen Maura Carrillo De Albornoz Calahorro Spain
P-024 Anxiety Disorders: comparative psychopathology between adults and the elderly Carmen Maura Carrillo De Albornoz Calahorro Spain
P-025 Depressive disorders: comparative between adults and the elderly Carmen Maura Carrillo De Albornoz Calahorro Spain
P-048 Cognitive enhancing interventions for people with bipolar disorder: a systematic review Dimosthenis Tsapekos United Kingdom
P-049 Mood Disorders in Incarcerated Young Offenders in Brazil Eduardo Alves Guilherme Brazil
P-050 Can I count on you? Social support, depression and suicide risk Eleanor Beale United States
P-051 Exploring the experiences of individuals with bipolar disorder diagnosed with borderline personality disorder Emma Tickle United Kingdom
P-052 A Network model of positive resource, temperament, childhood trauma and comorbid symptoms for patient with depressive disorders Hyu Jung Huh South Korea
P-053 Autonomic Responses to Emotional Stimuli While Sleep Deprived: Evidence of an Adaptive Mechanism Ilana Susie Hairston Israel
P-054 ADHD in childhood as a Bipolar Disorder predictive factor in adulthood Javier Domínguez Cutanda Spain
P-055 Immigration and cultural differences between first and second immigrants generation as a main factor to mood disorders: a case report Laura Carpio García Spain
P-056 A systematic review of pharmacological augmentation treatment guidelines for unipolar depression Lindsey Marwood United Kingdom
P-057 Parental Accommodation and Parental Depression are associated with Selective Mutism Levels in Children – Preliminary Results Maayan Shorer Israel
P-058 Depression history as a predictor of good opioid treatment outcome: A test of two potential explanations Margaret L Griffin United States
P-059 Prodromal features of Bipolar Disorder during adolescence and the importance of its identification Maria João Bastos Lobato Portugal
P-060 Relationship between parenting practices and mother and child psychopathological traits: a cross-sectional study Maria Nobile Italy
P-061 Neuropsychological functioning and early life stress from toddlerhood to adolescence: a systematic review Marta Maria Moreira United Kingdom
P-062 Admission rate and mental distress among patients with bipolar disorder in the perinatal period Michael Ioannou Sweden
P-063 Manic syndrome as the presenting feature of pancreatic cancer Pedro Oliveira Portugal
P-064 Treatment emergent affective switch and antidepressant treatment in bipolar depression: a retrospective study Pedro Oliveira Portugal
P-065 Symptom effects of caffeine intake in patients with bipolar disorder: a systematic review Rebecca Strawbridge United Kingdom
P-066 Morningness-Eveningness Scores Predict Outcomes Differentially for Depressed Patients Attending Morning vs. Afternoon Day Treatment Streams Robert Levitan Canada
P-067 Overdose and Suicidal Motivation in Adults with Opioid Use Disorder Roger D. Weiss United States
P-068 A systematic review to investigate what constitutes early age at onset of Bipolar disorder Sorcha Bolton United Kingdom
P-069 What predicts verbal learning and memory in euthymic patients with bipolar disorder? – Is it anxiety, intelligence or other factors? Thomas Daniel Meyer United States
P-070 Sexual health and its correlates in individuals with mood disorders Thomas Daniel Meyer United States
P-071 Cognitive function, depressive symptoms and psychosocial function in patients with major depressive disorder treated with antidepressants: A longitudinal analysis of PERFORM-J data Tomiki Sumiyoshi Japan
P-072 Genetic and Environmental Influences on the Relationship between Sleep and Depression in Adolescent Twins Victoria S. OCallaghan Australia
P-073 Characteristics of affective temperaments and neuroticism in melancholic depression: a cross-sectional study Yu Tamada Japan
P-074 Who benefits from standard antidepressants? Preliminary findings supporting a moral sentiment-task based functional MRI measure for personalising treatment  Diede Fennema  United Kingdom
P-075 The Antidepressant Advisor: A Decision Support System for UK primary care - a feasibility study Phillippa Harrison  United Kingdom